Determination of dipole for tissue conductance communication

Patent metadata

Field	Value
Publication number	US-9867990-B2
Application number	US-91578810-A
Country	US
Kind code	B2
Filing date	Oct 29, 2010
Priority date	Oct 29, 2010
Publication date	Jan 16, 2018
Grant date	Jan 16, 2018

Abstract

Aspects of the present disclosure include a medical device system including an implantable medical device and an external device with three or more electrodes configured to contact a patient's skin. The external device either transmits or receives a test signal to or from the implantable medical device using a plurality of possible receive dipoles, where each possible receive dipole is formed by a pair of electrodes. A signal quality monitor, either at the implantable medical device or at the external device, measures a signal quality for the possible receive dipoles.

First claim

The invention claimed is:

1. An external device comprising:
a plurality of three or more electrodes positionable at different tissue contact points on an external tissue surface of a patient;
a communication unit configured to communicate with an implantable medical device via a plurality of dipoles formed by different combinations of two of the three or more electrodes, wherein the communication unit is further configured to transmit a signal causing the implantable medical device to enter a test mode;
a processor configured to identify a dipole that provides at least a minimum signal quality with the implantable medical device, wherein the processor identifies the dipole that provides the at least minimum signal quality based on one or more test signals generated during the test mode; and
a test analysis module configured to present to a user an indication of the dipole identified based on the one or more test signals.

2. The external device of claim 1 , wherein the communication unit is configured to transmit the one or more test signals using the plurality of dipoles.

3. The external device of claim 2 , wherein the processor is configured to identify the dipole that provides at least the minimum signal quality with the implantable medical device based at least in part on signal quality test results transmitted from the implantable medical device.

4. The external device of claim 2 , wherein the processor is configured to identify the dipole that provides at least the minimum signal quality with the implantable medical device based at least in part on a signal from the implantable medical device identifying the dipole that provides at least the minimum signal quality with the implantable medical device.

5. The external device of claim 1 , wherein the communication unit is configured to receive the one or more test signals from the implantable medical device using the plurality of dipoles.

6. The external device of claim 5 , wherein the processor is configured to identify the dipole that provides at least the minimum signal quality with the implantable medical device based at least in part on the one or more test signals received from the implantable medical device.

7. The external device of claim 1 , wherein the one or more test signals comprise signals transmitted at different power levels, and wherein the processor is further configured to identify the dipole that provides the at least minimum signal quality with the implantable medical device based at least in part on a power level of the dipole that provides at least the minimum signal quality.

8. A medical device system comprising:
an implantable medical device (IMD) comprising:
a first communication unit;
a first processor;

an external device comprising:
a plurality of three or more electrodes positionable at different tissue contact points on an external tissue surface of a patient;
a second communication unit configured to communicate with the IMD via a plurality of dipoles formed by different combinations of two of the three or more electrodes, wherein the second communication unit is further configured to transmit a signal causing the implantable medical device to enter a test mode; and
a second processor configured to identify a dipole that provides at least a minimum signal quality with the IMD, wherein the processor identifies the dipole that provides the at least minimum signal quality based on one or more test signals generated during the test mode, wherein the processor is further configured to present to a user an indication of the dipole identified based on the one or more test signals.

9. The medical device system of claim 8 , wherein the second communication unit is configured to transmit, to the IMD, the one or more test signals using the plurality of dipoles.

10. The medical device system of claim 9 , wherein the second processor is configured to identify the dipole that provides at least the minimum signal quality with the IMD based at least in part on signal quality test results received from the IMD.

11. The medical device system of claim 9 , wherein the first processor is configured to identify the dipole that provides at least the minimum signal quality with the IMD based at least in part on the test signals, and the first communication unit is configured to transmit to the external device an indicator of the dipole that provides at least the minimum signal quality with the 1 MB.

12. The medical device system of claim 8 , wherein the first communication unit is configured to transmit the one or more test signals to the external device, and the second communication unit is configured to receive the one or more test signals via the plurality of dipoles formed by different combinations of the electrodes.

13. The medical device system of claim 12 , wherein the second processor is configured to identify the dipole that provides at least the minimum signal quality with the IMD based at least in part on the one or more test signals received from the IMD.

14. The medical device system of claim 8 , wherein the external device is configured to transmit to the 1 MB an instruction, and in response to receiving the instruction, the first communication unit is configured to either increase or decrease a signal transmission power.

15. The medical device system of claim 8 , wherein
the first communication unit is configured to
receive, from the external device, the one or more test signals via the plurality of dipoles formed by different combinations of electrodes;
identify within each test signal, a signal identification for the test signals; and

wherein the IMD further comprises:
a signal quality monitor configured to determine a signal quality for each test signal;
a communication transmitting unit configured to transmit, to the external device, an indicator of at least one signal identification for at least one test signal.

16. The medical device system of claim 8 , wherein the one or more test signals comprise signals transmitted at different power levels, and wherein the second processor is further configured to identify the dipole that provides the at least minimum signal quality with the implantable medical device based at least in part on a power level of the dipole that provides at least the minimum signal quality.

17. A method comprising:
transmitting a signal causing an implantable medical device (IMD) to enter a test mode;
communicating with the IMD via a plurality of dipoles formed by different combinations of two electrodes positioned at different tissue contact points on an external tissue surface of a patient, wherein the different combinations of two electrodes are formed from a plurality of three or more electrodes;
identifying a dipole that provides at least a minimum signal quality with the implantable medical device based on one or more test signals generated during the test mode; and
presenting to a user an indication of the dipole identified based on the one or more test signals.

18. The method of claim 17 , wherein the communicating comprises transmitting the one or more test signals to the IMD using the plurality of dipoles.

19. The method of claim 18 , further comprising:
receiving signal quality test results from the IMD; and
wherein the identifying the dipole that provides at least the minimum signal quality with the implantable medical device is based at least in part on the signal quality test results.

20. The method of claim 18 , further comprising:
receiving, from the IMD, a signal identifying t

Assignees

• Cinbis Can
• Anderson David A
• Reinert Michael A
• Shen Xiaonan
• Carney James K
• Terry Michael B
• Medtronic Inc

Inventors

• Cinbis Can
• Anderson David A
• Reinert Michael A
• Shen Xiaonan
• Carney James K
• Terry Michael B

Classifications

• A61B5/0028

  Body tissue as transmission medium, i.e. transmission systems where the medium is the human body · CPC title

• A61N1/37217 Primary

  characterised by the communication link, e.g. acoustic or tactile · CPC title

• H04B13/005

  Transmission systems in which the medium consists of the human body · CPC title

• A61N1/08

  Arrangements or circuits for monitoring, protecting, controlling or indicating {(for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925)} · CPC title